BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10386559)

  • 1. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific Affairs. American Medical Association.
    Tan L; Williams MA; Khan MK; Champion HC; Nielsen NH
    JAMA; 1999 Jun 23-30; 281(24):2330-9. PubMed ID: 10386559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The research programme on transmissible spongiform encephalopathies in Britain with special reference to bovine spongiform encephalopathy.
    Bradley R
    Dev Biol Stand; 1993; 80():157-70. PubMed ID: 8270105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic.
    Nathanson N; Wilesmith J; Griot C
    Am J Epidemiol; 1997 Jun; 145(11):959-69. PubMed ID: 9169904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
    Schonberger LB
    Infect Dis Clin North Am; 1998 Mar; 12(1):111-21. PubMed ID: 9494833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization consultation on public health issues related to bovine spongiform encephalopathy and the emergence of a new variant of Creutzfeldt-Jakob disease.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):295-6, 303. PubMed ID: 8598828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: implications for Australia.
    Goldwater PN
    Med J Aust; 2001 Aug; 175(3):154-8. PubMed ID: 11548083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns.
    Brown P; Will RG; Bradley R; Asher DM; Detwiler L
    Emerg Infect Dis; 2001; 7(1):6-16. PubMed ID: 11266289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Current questions].
    Brugère-Picoux J
    Bull Acad Natl Med; 1996 Feb; 180(2):291-9; discussion 300-3. PubMed ID: 8705376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine spongiform encephalopathy in the United Kingdom: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):691-4. PubMed ID: 8313487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal transmissible subacute spongiform encephalopathies: scrapie in sheep and bovine spongiform encephalopathy].
    Parodi AL
    Clin Exp Pathol; 1999; 47(3-4):133-44. PubMed ID: 10472733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine spongiform encephalopathy (BSE). WHO Consultation on public health issues related to BSE and the emergence of a new variant of Creutzfeldt-Jakob disease.
    Wkly Epidemiol Rec; 1996 Apr; 71(15):113-5. PubMed ID: 8624257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bovine spongiform encephalopathy and food safety].
    Zaaijer HL
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1052-7. PubMed ID: 10850107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine spongiform encephalopathy and new variant Creutzfeldt-Jakob disease: an overview.
    Patterson WJ; Painter MJ
    Commun Dis Public Health; 1999 Jan; 2(1):5-13. PubMed ID: 10462888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. British BSE reckoning tells a dismal tale.
    Butler D
    Nature; 1998 Apr; 392(6676):532-3. PubMed ID: 9560136
    [No Abstract]   [Full Text] [Related]  

  • 15. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: a risk analysis.
    Liberski PP
    Folia Neuropathol; 2000; 38(4):143-50. PubMed ID: 11693716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BSE: can we predict the future?
    Plum J
    Verh K Acad Geneeskd Belg; 1997; 59(5):435-49. PubMed ID: 9490927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transmission dynamics of BSE and vCJD.
    Ghani AC; Donnelly CA; Ferguson NM; Anderson RM
    C R Biol; 2002 Jan; 325(1):37-47. PubMed ID: 11862621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies.
    Asher DM
    Dev Biol Stand; 1999; 99():41-4. PubMed ID: 10404874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.
    Cousens SN; Zeidler M; Esmonde TF; De Silva R; Wilesmith JW; Smith PG; Will RG
    BMJ; 1997 Aug; 315(7105):389-95. PubMed ID: 9277601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials of protecting Poland from acquiring bovine spongiform encephalopathy.
    Kita J; Maciołek H
    Arch Immunol Ther Exp (Warsz); 1998; 46(2):65-8. PubMed ID: 9613702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.